Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors

by I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko
Published 2014

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia

by N. I. Bilous, I. V. Abramenko, A. A. Chumak, I. S. Dyagil, Z. V. Martina
Published 2014

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy

by I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko, A. I. Gordienko, M. V. Diachenko, I. S. Dyagil
Published 2015